Nathan Connell: Calling All Hematology Professionals Interested in Quality Improvement!
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
”Calling All Hematology Professionals Interested in Quality Improvement!
The application window is OPEN for the American Society of Hematology (ASH) Quality Improvement Training Institute (QITI)—a phenomenal, 16-month hybrid program designed to build clinician leadership and drive systems-based change in hematologic care.
This is a must for anyone looking to advance their career in systems-based hematology and become a leader in quality improvement.
Why QITI stands out:
- Hands-on Experience: Teams work on two structured QI projects at their home institution, directly addressing clinical gaps and enhancing patient experience, outcomes, and equity.
- Expert Coaching: Each team is paired with an experienced QI coach for individualized, 16-month mentorship.
- Free to Participate: ASH covers travel, lodging, and meal expenses for up to three team members attending the mandatory in-person workshops in Washington, DC.
QITI is designed for interdisciplinary care teams in North America. If you are passionate about continuous improvement and want to formally integrate QI methodology into your practice, this is your chance!
The 2026-2027 application closes January 5, 2026.
Learn more and apply here.”
Stay updated on all opportunities with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025